Stuart Therapeutics, a clinical stage pharmaceutical company based in Stuart, FL, specializes in developing a unique synthetic protein targeting helical collagen in the human body. Their innovative platform technology, PolyColTM, aims to repair disease-damaged helical collagen in tissues and membranes.
Founded in 2018, Stuart Therapeutics is committed to advancing new and effective solutions for chronic eye diseases such as Dry Eye Disease, Glaucoma, Dry Age-Related Macular Degeneration, and Myopia. With a team of experts in ophthalmology research and pharmaceutical development, the company focuses on preserving visual function and sight for patients with chronic eye conditions.
Generated from their business information